Sturion currently Managing Director of Janssen Mexico succeeds Massimo Scaccabarozzi in the role of Managing Director Janssen Italia who, after leading Janssen’s business in Italy for 20 years, was appointed Head of External Affairs for the three companies in which Johnson & Johnson is divided in our country.
08 JUNE – Janssen, a pharmaceutical company of the Johnson & Johnson Group, today announced that Mario Sturion, currently Managing Director of Janssen Mexico, he has been appointed Managing Director of Janssen Italia. After leading Janssen’s business in Italy for 20 years, Massimo Scaccabarozzi he was appointed Head of External Affairs for the three companies in which Johnson & Johnson is divided in our country.
Mario Sturion is an established business leader, recognized for his support for talent development and the promotion of digital transformation projects, as well as for his commitment to initiatives in favor of diversity, equity and inclusion. During his 25-year career at Johnson & Johnson, Sturion has held a number of executive positions of increasing responsibility in Latin America and North America, in sales, marketing and management.
Mario Sturion will lead the company’s pharmaceutical business in Italy, which employs more than 1,500 people divided between the Cologno Monzese headquarters and the Latina plant, one of the most innovative production sites in the world with a production of approximately 5 billion oral treatments. year and exports amounted to nearly 95% to over 100 countries. Based in Milan, Mario will report to Kris Sterkens Company Group Chairman of Janssen EMEA.
“It has been a privilege to lead Janssen’s business in Mexico and to have had the opportunity to impact the lives of so many patients,” said Mario Sturion. “I am thrilled with this new chapter in my career and look forward to leading the company in this time of profound transformation.”
“Janssen Italia is one of the largest companies in our sector in EMEA and I am honored to follow in the footsteps of Massimo Scaccabarozzi and continue to work every day for a future in which diseases are a thing of the past, collaborating with all the actors of the healthcare ecosystem to make a difference. “
Over the past 20 years at Johnson & Johnson, Massimo Scaccabarozzi has been appreciated for having been able to seize the opportunities to access the market and for how he has faced the challenges of the complex health sector. In his new role, Scaccabarozzi will work on the external positioning of J&J in Italy, in the three sectors in which the group is divided: Pharmaceutical, Medical Devices and Consumer. He will also retain the responsibility of Chairman of the Board of Directors of Janssen Italy and of the Johnson & Johnson Foundation in Italy.
08 June 2021
© All rights reserved
Other articles in Science and Drugs
QS Edizioni srl
Via Boncompagni, 16
00187 – Roma
Via Vittore Carpaccio, 18
00147 Rome (RM)
Francesco Maria Avitto
President and CEO
Copyright 2013 © QS Edizioni srl. All rights reserved
– P.I. 12298601001
– registration in the ROC n. 23387
– registration at the Court of Rome n. 115/3013 of 22/05/2013
All rights reserved.